Variables | Unit A | Unit B | |||||
---|---|---|---|---|---|---|---|
Period 1(2008 to 2010)c , n = 1,110 | Period 2(2011)c , n = 552 | P -value | Period 1 (2008 to 2010)b , n = 646 | Period 2(2011)b , n = 250 | P -value | ||
Categorical variables, n (%) | |||||||
Male sex | 669 (60.3) | 348 (63.0) | 0.28 | 430 (66.6) | 157 (62.8) | 0.29 | |
Antibioticsd | 759 (68.4) | 436 (79.0) | <0.001 | 288 (44.6) | 148 (59.2) | <0.001 | |
Trauma patients | 44 (4.0) | 8 (1.5) | 0.006 | 137 (21.2) | 15 (6.0) | <0.001 | |
Diagnostic categoryd | 0.14 | 0.004 | |||||
Medical ICU | 1,030 (92.8) | 522 (94.6) | 248 (38.4) | 121 (48.4) | |||
Emergency surgical ICU | 50 (4.5) | 14 (2.5) | 181 (28.0) | 46 (18.4) | |||
Scheduled surgical ICU | 30 (2.7) | 16 (2.9) | 217 (33.6) | 83 (33.2) | |||
Patient origind | <0.001 | 0.005 | |||||
Home or nursing home | 473 (42.6) | 437 (79.2) | 140 (21.7) | 65 (26.0) | |||
Short-stay unit | 559 (50.4) | 103 (18.7) | 404 (62.5) | 146 (58.4) | |||
Long-stay unit | 29 (2.6) | 7 (1.3) | 24 (3.7) | 0 (0.0) | |||
ICU | 49 (4.4) | 5 (0.9) | 78 (12.1) | 39 (15.6) | |||
Immunodeficiencyd | 243 (21.9) | 102 (18,5) | 0.16 | 329 (51.0) | 101 (40.4) | 0.014 | |
Invasive mechanical ventilation | 800 (72.1) | 369 (66.9) | 0.03 | 442 (68.4) | 131 (52.4) | <0.001 | |
Central venous catheterization | 737 (66.4) | 383 (69.4) | 0.22 | 518 (80.2) | 220 (88.0) | 0.006 | |
Urinary catheterization | 1,027 (92.5) | 494 (89.5) | 0.04 | 557 (86.2) | 217 (86.8) | 0.82 | |
Died in-hospital | 253 (22.8) | 109 (19.8) | 0.16 | 93 (14.4) | 37 (14.8) | 0.88 | |
Continuous variable, mean (SD) | |||||||
Length of ICU stay, days | 10.1 (15.4) | 7.1 (8.5) | <0.001 | 12.1 (22.8) | 11.1 (19.0) | 0.54 | |
Age, yearsd | 61.2 (16.9) | 62.7 (16.9) | 0.10 | 59.1 (16.0) | 61.8 (16.6) | 0.03 | |
SAPS IId | 51.7 (19.1) | 51.6 (18.3) | 0.92 | 41.2 (20.0) | 37.7 (16.3) | 0.014 | |
Length of invasive mechanical ventilation, days | 8.7 (15.1) | 5.7 (7.8) | <0.001 | 11.4 (25.7) | 11.0 (20.0) | 0.85 | |
Length of urinary catheterization, days | 9.7 (14.1) | 6.2 (6.5) | <0.001 | 10.6 (19.2) | 9.6 (15.8) | 0.49 | |
Incidence of overall HAIs | |||||||
Number of HAIs | 149 | 50 | 116 | 38 | |||
Attack ratee | 13.4 | 9.1 | 0.01 | 18.0 | 15.2 | 0.33 | |
Incidence of overall HAIsf (95% CI) | 18.0 (15.3 to 21.2) | 15.2 (11.3 to 20.0) | 0.29 | 23.5 (19.4 to 28.2) | 21.8 (15.5 to 30.0) | 0.71 | |
Incidence of 3GC-RE-related HAIs | |||||||
Number of 3GC-RE-related HAIs | 56 | 5 | 20 | 5 | |||
Attack ratee | 5.1 | 0.9 | <0.001 | 3.1 | 2.0 | 0.37 | |
Incidence of 3GC-RE-related HAIsf (95% CI) | 5.4 (4.1 to 7.0) | 1.3 (0.4 to 3.0) | <0.001 | 2.8 (1.7 to 4.3) | 1.9 (0.6 to 4.5) | 0.48 |